Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG30027)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
OIP5-AS1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Phospholipid hydroperoxide glutathione peroxidase (GPX4) [Suppressor]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Target for Ferroptosis | Suppressor | |||
Responsed Disease | Oesophageal cancer | ICD-11: 2B70 | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Fatty acid metabolism | hsa01212 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
Eca-109 cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_6898 |
TE-13 cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_4463 | |
TE-1 cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1759 | |
T.Tn cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_3175 | |
hOECs (Normal oesophageal epithelial cells) | ||||
Response regulation | OIP5-AS1 inhibition significantly inhibited Oesophageal cancer (EC) cell viability and proliferation, induced ferroptosis, and downregulated GPX4 levels, while GPX4 reversed these effects. | |||
Cystine/glutamate transporter (SLC7A11) [Driver; Suppressor]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [2] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Prostate cancer | ICD-11: 2C82 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell invasion | |||||
In Vitro Model |
PC-3 cells | Prostate carcinoma | Homo sapiens | CVCL_0035 | |
DU145 cells | Prostate carcinoma | Homo sapiens | CVCL_0105 | ||
In Vivo Model |
A total of 2 x 106 PC3 and PC3/Cd cells were subcutaneously injected into the right flanks of 4-week-old male Balb/c nude mice. Tumor burdens were closely monitored by tumor volumes. When the largest tumors reached a size of 1.0 cm3, all mice were sacrificed due to ethical considerations. Moreover, the final tumor weight was also recorded.
Click to Show/Hide
|
||||
Response regulation | OIP5-AS1 served as an endogenous sponge of miR-128-3p to regulate the expression of SLC7A11, a surrogate marker of ferroptosis. Moreover, miR-128-3p decreased cell viability by enhancing ferroptosis. Taken together, lncRNA OIP5-AS1 promotes prostate cancer progression and ferroptosis resistance through miR-128-3p/SLC7A11 signaling. | ||||
Oesophageal cancer [ICD-11: 2B70]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | OIP5-AS1 (IncRNA) | lncRNA | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Fatty acid metabolism | hsa01212 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
Eca-109 cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_6898 |
TE-13 cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_4463 | |
TE-1 cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1759 | |
T.Tn cells | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_3175 | |
hOECs (Normal oesophageal epithelial cells) | ||||
Response regulation | OIP5-AS1 inhibition significantly inhibited Oesophageal cancer (EC) cell viability and proliferation, induced ferroptosis, and downregulated GPX4 levels, while GPX4 reversed these effects. | |||
Prostate cancer [ICD-11: 2C82]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [2] | ||||
Target Regulator | OIP5-AS1 (IncRNA) | lncRNA | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell invasion | |||||
In Vitro Model |
PC-3 cells | Prostate carcinoma | Homo sapiens | CVCL_0035 | |
DU145 cells | Prostate carcinoma | Homo sapiens | CVCL_0105 | ||
In Vivo Model |
A total of 2 x 106 PC3 and PC3/Cd cells were subcutaneously injected into the right flanks of 4-week-old male Balb/c nude mice. Tumor burdens were closely monitored by tumor volumes. When the largest tumors reached a size of 1.0 cm3, all mice were sacrificed due to ethical considerations. Moreover, the final tumor weight was also recorded.
Click to Show/Hide
|
||||
Response regulation | OIP5-AS1 served as an endogenous sponge of miR-128-3p to regulate the expression of SLC7A11, a surrogate marker of ferroptosis. Moreover, miR-128-3p decreased cell viability by enhancing ferroptosis. Taken together, lncRNA OIP5-AS1 promotes prostate cancer progression and ferroptosis resistance through miR-128-3p/SLC7A11 signaling. | ||||
References